The evaluation of the efficacy of adalimumab in refractory non-infectious uveitis with ultra-widefield fundus fluorescein angiography.

Dilek UzluBüşra KöseNurettin AkyolHidayet ErdölMurat Günay

Published in: International ophthalmology (2022)

Adalimumab was found to be effective in establishing inflammation control by reducing drug burden, controlling retinal vascular leakage and choroidal inflammation in refractory uveitis.

Keyphrases

juvenile idiopathic arthritis
optical coherence tomography
diabetic retinopathy
oxidative stress
rheumatoid arthritis
ankylosing spondylitis
disease activity
optic nerve
computed tomography
high resolution
hidradenitis suppurativa
risk factors
emergency department
mass spectrometry
adverse drug